Recruiting
Colorectal cancer metastatic+2
RecruitingSafety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer
Registered drugNo placebo
Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer
Registered drugNo placebo
- Disease:Colorectal cancer metastaticProstate cancer metastatic+1
- Substances:AldesleukinCC-38+3
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Aldesleukin
